IL165562A0 - Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers - Google Patents

Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

Info

Publication number
IL165562A0
IL165562A0 IL16556204A IL16556204A IL165562A0 IL 165562 A0 IL165562 A0 IL 165562A0 IL 16556204 A IL16556204 A IL 16556204A IL 16556204 A IL16556204 A IL 16556204A IL 165562 A0 IL165562 A0 IL 165562A0
Authority
IL
Israel
Prior art keywords
prodrugs
treatment
proton pump
imidazole derivatives
pump inhibitors
Prior art date
Application number
IL16556204A
Other languages
English (en)
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of IL165562A0 publication Critical patent/IL165562A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16556204A 2002-06-14 2004-12-05 Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers IL165562A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002175086 2002-06-14
JP2003041085 2003-02-19
PCT/JP2003/007546 WO2003105845A1 (fr) 2002-06-14 2003-06-13 Promedicaments de derives d'imidazole servant d'inhibiteurs de pompe a protons dans le traitement de l'ulcere gastro-duodenal

Publications (1)

Publication Number Publication Date
IL165562A0 true IL165562A0 (en) 2006-01-15

Family

ID=29738411

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16556204A IL165562A0 (en) 2002-06-14 2004-12-05 Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

Country Status (19)

Country Link
US (2) US7410981B2 (fr)
EP (2) EP1513527B1 (fr)
JP (1) JPWO2003106429A1 (fr)
KR (1) KR20050009751A (fr)
CN (1) CN1678315A (fr)
AR (1) AR040221A1 (fr)
AT (1) ATE437642T1 (fr)
AU (2) AU2003242390A1 (fr)
BR (1) BR0311801A (fr)
CA (2) CA2489361A1 (fr)
DE (1) DE60328603D1 (fr)
IL (1) IL165562A0 (fr)
MX (1) MXPA04012396A (fr)
NO (1) NO20050141L (fr)
OA (1) OA12867A (fr)
PE (1) PE20040563A1 (fr)
PL (1) PL373085A1 (fr)
TW (1) TW200307544A (fr)
WO (2) WO2003106429A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2327926T3 (es) 2004-04-28 2009-11-05 Hetero Drugs Limited Procedimiento de preparacion de compuestos de piridinilmetil-1h-benzimidazol en forma de enantiomeros simples o enantiomericamente enriquecidos.
EP2275088B2 (fr) 2005-02-25 2018-09-26 Takeda Pharmaceutical Company Limited Procédé de fabrication de granulés
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
EP2086543A2 (fr) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprenant des agents d'inhibition de la pompe à protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procédés d'utilisation
WO2009105568A1 (fr) 2008-02-20 2009-08-27 The Curators Of The University Of Missouri Composition comprenant une combinaison d'oméprazole et de lansoprazole, et un agent tampon, et ses méthodes d'utilisation
WO2011056652A1 (fr) 2009-10-28 2011-05-12 Newlink Genetics Dérivés imidazole comme inhibiteurs de l'ido
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
US10301254B2 (en) 2015-04-23 2019-05-28 Temple University—Of the Commonwealth System of Higher Education Substituted polycationic multi-quaternary ammonium salts as antimicrobial agents
CN109310674B (zh) * 2016-06-21 2022-07-08 纽约市哥伦比亚大学理事会 醛糖还原酶抑制剂及其使用方法
WO2018081347A1 (fr) 2016-10-26 2018-05-03 Temple University-Of The Commonwealth System Of Higher Education Composés amphiphiles polycationiques utiles en tant qu'agents antimicrobiens et leurs méthodes d'utilisation
US11590131B2 (en) 2017-07-28 2023-02-28 Applied Therapeutics, Inc. Compositions and methods for treating galactosemia
IT202200001022A1 (it) * 2022-01-21 2023-07-21 Exo Lab Italia Composti farmaceutici ibridi ottenuti mediante coniugazione di un inibitore delle pompe protoniche e un inibitore delle anidrasi carboniche

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
KR890000387B1 (ko) 1984-09-24 1989-03-16 디 엎존 캄파니 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
IL76839A (en) 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US4965269A (en) 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5614549A (en) * 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
DE19832060C2 (de) * 1998-07-16 2000-07-06 Siemens Ag Doppelbare Prozessoreinrichtung
US6542966B1 (en) * 1998-07-16 2003-04-01 Intel Corporation Method and apparatus for managing temporal and non-temporal data in a single cache structure
US6093734A (en) 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
CN1349526A (zh) * 1999-04-09 2002-05-15 巴斯福股份公司 凝血酶抑制剂的前药
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
WO2002004452A2 (fr) * 2000-07-07 2002-01-17 Neotherapeutics, Inc. Procédés pour le traitement de neuropathie périphérique induite par une pathologie et des états connexes
CA2425363A1 (fr) 2000-10-12 2003-04-10 Fumihiko Sato Composes derives de benzimidazole, leur procede de production et leur utilisation
IL154183A0 (en) * 2001-05-31 2003-07-31 Medarex Inc Cytotoxins, prodrugs, linkers and stabilizers useful therefor
WO2003027098A1 (fr) 2001-09-25 2003-04-03 Takeda Chemical Industries, Ltd. Compose de benzymidazole, procede de production et d'utilisation de celui-ci

Also Published As

Publication number Publication date
EP1513527B1 (fr) 2009-07-29
ATE437642T1 (de) 2009-08-15
AU2003242390A1 (en) 2003-12-31
KR20050009751A (ko) 2005-01-25
JPWO2003106429A1 (ja) 2005-10-13
DE60328603D1 (de) 2009-09-10
US20050222210A1 (en) 2005-10-06
AU2003242388A1 (en) 2003-12-31
EP1514870A4 (fr) 2006-08-23
AR040221A1 (es) 2005-03-16
CN1678315A (zh) 2005-10-05
NO20050141L (no) 2005-01-27
EP1513527A1 (fr) 2005-03-16
WO2003105845A1 (fr) 2003-12-24
TW200307544A (en) 2003-12-16
EP1514870A1 (fr) 2005-03-16
NO20050141D0 (no) 2005-01-11
CA2489470A1 (fr) 2003-12-24
OA12867A (en) 2006-09-15
US20060293371A1 (en) 2006-12-28
PE20040563A1 (es) 2004-10-21
PL373085A1 (en) 2005-08-08
CA2489361A1 (fr) 2003-12-24
BR0311801A (pt) 2005-04-12
US7410981B2 (en) 2008-08-12
WO2003106429A1 (fr) 2003-12-24
MXPA04012396A (es) 2005-06-17

Similar Documents

Publication Publication Date Title
NO20050141D0 (no) Prodrugs av imidazolderivater for anvendelse som protonpumpeinhibitorer ved behandlingen av f.eks. peptisk ulcus
AU2003213768A1 (en) Use of benzimidazole analogs in the treatment of cell proliferation
AU2003206785A1 (en) Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
WO2010038086A8 (fr) Nouveaux composés
UA104731C2 (ru) Ингибиторы р38 мар-киназ
EP1803709A4 (fr) Inhibiteurs de pompe a protons
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
AU2003258441A1 (en) System for performing proton therapy
AU2003241464A1 (en) Compositions and methods using proton pump inhibitors
GEP20084499B (en) USE OF INTERFERON-ß FOR TREATMENT OF RENAL FAILURE
EP1534278A4 (fr) Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation
WO2007120333A3 (fr) Inhibiteurs de kinase tétracycliques
AU2002366796A8 (en) Methods using proton pump inhibitors
HK1072379A1 (en) Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
PL1626736T3 (pl) Inhibitor c1 o krótkim okresie półtrwania do leczenia przejściowego
GB0403165D0 (en) Novel uses for proton pump inhibitors
WO2004098599A3 (fr) Agents pour le traitement de troubles du bas-ventre
TW200509921A (en) Alkaline salts
DK1597260T3 (da) Triazol forbindelser, der er anvendelige i behandling
GEP20094699B (en) THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING ß-INTERFERON
WO2003094967A3 (fr) Nouvelle combinaison destinee au traitement des troubles des voies aeriennes
MY140194A (en) Novel fusidic acid derivatives
AU2003205452A1 (en) Bmp inhibitors for the treatment of spondyloarthropathies
WO2003043614A3 (fr) Agents utiles pour le traitement des troubles des voies aeriennes
WO2003075926A8 (fr) Utilisation d'inhibiteurs de la pompe a protons pour traiter des troubles des voies respiratoires